January 16, 2009 – Notices – Final Guidances– Docket No. FDA-2007-D-0371, CFSAN 200846. Guidance for Industry: Evidence-Based Review System for the Scientific Evaluation of Health Claims. Pages 3059-3060 [FR Doc. E9-957] [TXT] [PDF] [PRE-PUB]
[Federal Register: January 16, 2009 (Volume 74, Number 11)]
[Notices]
[Page 3059-3060]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr16ja09-105]
———————————————————————–
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2007-D-0371 (formerly Docket No. 2007D-0125)]
Guidance for Industry: Evidence-Based Review System for the
Scientific Evaluation of Health Claims
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
SUMMARY: The Food and Drug Administration (FDA) is announcing the availability of a guidance document entitled “Guidance for Industry: Evidence-Based Review System for the Scientific Evaluation of Health Claims.” This guidance outlines the agency’s approach to the review of the scientific evidence for health claims that meet the significant
scientific agreement standard (SSA) and qualified health claims.
Elsewhere in this issue of the Federal Register, FDA is announcing the withdrawal of the guidance documents entitled “Guidance for Industry and FDA: Interim Evidence-Based Ranking System for Scientific Data” and “Guidance for Industry: Significant Scientific Agreement in the Review of Health Claims for Conventional Foods and Dietary
Supplements.”
Tags: CFSAN, FDA, FEDERAL REGISTER, Health Claims
